SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Can social prescribing put the 'social' into the biopsychosocial management of people with long-term musculoskeletal disorders?

O'Sullivan, DJ; Bearne, LM; Harrington, JM; McVeigh, JG (2023) Can social prescribing put the 'social' into the biopsychosocial management of people with long-term musculoskeletal disorders? Musculoskeletal Care, 21 (4). pp. 1341-1352. ISSN 1557-0681 https://doi.org/10.1002/msc.1810
SGUL Authors: Bearne, Lindsay Mary

[img] Microsoft Word (.doc) Accepted Version
Restricted to Repository staff only until 28 August 2024.
Available under License ["licenses_description_publisher" not defined].

Download (659kB)

Abstract

BACKGROUND: Chronic musculoskeletal disorders (MSD) are a significant burden on individuals' quality of life and society and are made more complex by the presence of multimorbidity. It is recommended that interventions targeting MSD be sustainable, equitable and incorporate the biopsychosocial model of care (BPS). AIMS: A criticism of the BPS approach is that the social component of this model is not addressed adequately during the management of people with long-term MSD and that a gap exists between theory and implementation. The use of social prescribing (SP) as an intervention to bridge this gap is discussed. RESULTS AND DISCUSSION: Social prescribing is a holistic non-medical person-centered approach to well-being that utilizes link workers (LW) to support individuals with long-term conditions (LTC) in the community. Social prescribing referrals are received from primary healthcare practitioners to LW and range from light touch signposting for employment or financial advice to more intensive support for LTC such as obesity, decreased physical activity and mental health needs. CONCLUSION: There is evidence to suggest that SP interventions are effective in the management of LTC; however, due to the paucity of high-quality evidence, it is difficult to be conclusive. Large-scale randomised controlled trials are recommended to support the use of SP interventions in the management of LTC.

Item Type: Article
Additional Information: This is the pre-peer reviewed version of the following article: O’Sullivan, D. J., Bearne, L. M., Harrington, J. M., & McVeigh, J. G. (2023). Can social prescribing put the ‘social’ into the biopsychosocial management of people with long-term musculoskeletal disorders? Musculoskeletal Care, 21(4), 1341–1352, which has been published in final form at https://doi.org/10.1002/msc.1810. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
Keywords: biopsychosocial, link worker, long-term musculoskeletal conditions, multimorbidity, social prescribing, 1110 Nursing, Arthritis & Rheumatology
SGUL Research Institute / Research Centre: Academic Structure > Population Health Research Institute (INPH)
Journal or Publication Title: Musculoskeletal Care
ISSN: 1557-0681
Language: eng
Dates:
DateEvent
11 December 2023Published
28 August 2023Published Online
9 August 2023Accepted
Publisher License: Publisher's own licence
PubMed ID: 37639305
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115644
Publisher's version: https://doi.org/10.1002/msc.1810

Actions (login required)

Edit Item Edit Item